Ethinylestradiol/norelgestromin

Drug Profile

Ethinylestradiol/norelgestromin

Alternative Names: AP-1081; Contraceptive ATD™ Gel; Ethinylestradiol/norelgestromin transdermal - Antares Pharma

Latest Information Update: 06 Jul 2010

Price : $50

At a glance

  • Originator Antares Pharma
  • Class Alkylated estrogenic steroids; Hormonal contraceptives; Norpregnatrienes
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Contraception

Most Recent Events

  • 08 Apr 2005 Preclinical trials in Contraception/Pregnancy (Prevention) in USA (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top